Entera Bio's oral GLP-2 analog shows longer half-life, comparable peak levels to Gattex.

Retrieved on: 2025-09-15 20:53:06

Tags for this article:

Biomolecules

Glucagon-like peptide-2

Anti-diabetic drugs

Peptide hormones

GLP-1 receptor agonists

Piperidines

Gattex

Click the tags to see associated articles and topics

Entera Bio's oral GLP-2 analog shows longer half-life, comparable peak levels to Gattex.. View article details on hiswai:

Excerpt

Entera Bio (NASDAQ: ENTX) has made significant strides in the development of oral peptide therapies, presenting compelling preclinical data for OPK- ...

Article found on: www.ainvest.com

View Original Article